G. Magelund

895 total citations
13 papers, 733 citations indexed

About

G. Magelund is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Neurology. According to data from OpenAlex, G. Magelund has authored 13 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 4 papers in Psychiatry and Mental health and 3 papers in Neurology. Recurrent topics in G. Magelund's work include Neuroscience and Neuropharmacology Research (6 papers), Neurological disorders and treatments (3 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). G. Magelund is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Neurological disorders and treatments (3 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). G. Magelund collaborates with scholars based in Denmark, Armenia and United States. G. Magelund's co-authors include Jørgen Scheel‐Krüger, J. Arnt, Jes Gerlach, Maria C. Olianas, Dympna Casey, Uffe Juul Povlsen, Per Bech, Søren Korsgaard, Marianne Bjerre and Barbara Przewłocka and has published in prestigious journals such as Life Sciences, Psychopharmacology and Acta Psychiatrica Scandinavica.

In The Last Decade

G. Magelund

13 papers receiving 696 citations

Peers

G. Magelund
D.L. Murphy United States
Ana Hitri United States
Kevin P. Nanry United States
Mark Roffman United States
S Caldecott-Hazard United States
A. Sayers United Kingdom
Peter A. Rao United States
Joel E. Kleinman United States
Rodrigo Labarca United States
Bruce I. Diamond United States
D.L. Murphy United States
G. Magelund
Citations per year, relative to G. Magelund G. Magelund (= 1×) peers D.L. Murphy

Countries citing papers authored by G. Magelund

Since Specialization
Citations

This map shows the geographic impact of G. Magelund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Magelund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Magelund more than expected).

Fields of papers citing papers by G. Magelund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Magelund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Magelund. The network helps show where G. Magelund may publish in the future.

Co-authorship network of co-authors of G. Magelund

This figure shows the co-authorship network connecting the top 25 collaborators of G. Magelund. A scholar is included among the top collaborators of G. Magelund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Magelund. G. Magelund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gerlach, Jes, Søren Korsgaard, G. Magelund, et al.. (1993). The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validity. Acta Psychiatrica Scandinavica. 87(4). 244–252. 121 indexed citations
2.
Kirkegaard, C., et al.. (1988). The effect of sodium valproate on serum cortisol levels in healthy subjects and depressed patients. Acta Psychiatrica Scandinavica. 77(2). 170–174. 2 indexed citations
3.
Magelund, G., et al.. (1981). The role of GABA in the basal ganglia and limbic system for behaviour.. PubMed. 29. 23–36. 31 indexed citations
4.
Scheel‐Krüger, Jørgen & G. Magelund. (1981). GABA in the entopeduncular nucleus and the subthalamic nucleus participates in mediating dopaminergic striatal output functions. Life Sciences. 29(15). 1555–1562. 32 indexed citations
5.
Scheel‐Krüger, Jørgen, et al.. (1981). Role of GABA in the striatal output system: globus pallidus, nucleus entopeduncularis, substantia nigra and nucleus subthalamicus.. PubMed. 30. 165–86. 97 indexed citations
6.
Scheel‐Krüger, Jørgen, J. Arnt, G. Magelund, et al.. (1980). Behavioural functions of GABA in basal ganglia and limbic system. Brain Research Bulletin. 5. 261–267. 56 indexed citations
8.
Magelund, G., et al.. (1980). Gamma-Acetylenic GABA in tardive dyskinesia.. PubMed. 24. 577–80. 14 indexed citations
9.
Casey, Daniel E., et al.. (1979). Gamma-acetylenic GABA in tardive dyskinesia. Brain Research Bulletin. 4(5). 698–698. 8 indexed citations
10.
Magelund, G., Jes Gerlach, & Dympna Casey. (1979). Neuroleptic‐potentiating effect of α‐methyl‐p‐tyrosine compared with haloperidol and placebo in a double‐blind cross‐over trial. Acta Psychiatrica Scandinavica. 60(2). 185–189. 14 indexed citations
11.
Arnt, J., Jørgen Scheel‐Krüger, G. Magelund, & Povl Krogsgaard‐Larsen. (1979). Muscimol and related GABA receptor agonists: the potency of GABAergic drugs in vivo determined after intranigral injection. Journal of Pharmacy and Pharmacology. 31(1). 306–313. 34 indexed citations
12.
Scheel‐Krüger, Jørgen, et al.. (1978). GABA-dopamine interaction in substantia nigra and nucleus accumbens--relevance to behavioral stimulation and stereotyped behavior.. PubMed. 19. 343–6. 12 indexed citations
13.
Scheel‐Krüger, Jørgen, J. Arnt, & G. Magelund. (1977). Behavioural stimulation induced by muscimol and other GABA agonists injected into the substantia nigra. Neuroscience Letters. 4(6). 351–356. 243 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026